Fibrosis Hepática
The Baveno VII concept of cirrhosis recompensation.
A multi-society Delphi consensus statement on new fatty liver disease nomenclature.
Global epidemiology of cirrhosis — aetiology, trends and predictions.
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.
Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis.
Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis.
Prevalence and Independent Factors for Fatty Liver and Significant Hepatic Fibrosis Using B-Mode Ultrasound Imaging and Two Dimensional-Shear Wave Elastography in Health Check-up Examinees.
SARS-CoV- 2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus
Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis
